Obstructive Sleep Aponea (moderate to severe) and Overweight
NOW RECRUITING
-
Adelaide SA
Efficacy and Safety of a new medication in Participants with Obstructive Sleep Apnea and Obesity or Overweight who are not diabetic. Participants must be unable or unwilling to use CPAP and have not used this in the last 4 weeks.
- Age > 18 years
- Known moderate to severe OSA (free repeat sleep study during screening)
- BMI ≥27kg/m2
- At least one self reported unsuccessful dietary effort to reduce body weight
- Not diabetic
- Planned or prior surgery for obesity (some exceptions)
- No active cancer or history of cancer in last 5 years (some exceptions)
- Not using Mounjaro/Ozempic type medications for at least 90 days prior to screening
Outpatient Visit
- Screening Visit
- Clinic visit every 4 weeks
Payment / Remuneration
- Clinic visits $75
- Fasting visit meal reimbursement $48
Information for Practitioners
- Renal impairment eGFR <30mL/min/1.73m2
- Evidence of autoimmune disease with treatment of systemic glucorticoids
- History of MI, CVA, Angina, revascularisation, heart failure hospitalisation within 90 days of screening
- No history of unstable mental health disorder within last 2 years